M&A Deal Summary

Shire Acquires ViroPharma

On November 11, 2013, Shire acquired life science company ViroPharma for 4.2B USD

Acquisition Highlights
  • This is Shire’s 7th transaction in the Life Science sector.
  • This is Shire’s 4th largest (disclosed) transaction.
  • This is Shire’s 6th transaction in the United States.
  • This is Shire’s 1st transaction in Pennsylvania.

M&A Deal Summary
Date 2013-11-11
Target ViroPharma
Sector Life Science
Buyer(s) Shire
Deal Type Add-on Acquisition
Deal Value 4.2B USD
Advisor(s) Skadden, Arps, Slate, Meagher & Flom (Legal)

Target

ViroPharma

Exton, Pennsylvania, United States
ViroPharma, Inc. is a pharmaceutical company committed to the commercialization, development, and discovery of new antiviral medicines.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Shire

Dublin, Ireland
Category Company
Founded 1986
Sector Life Science
Employees5,548
Revenue 6.4B USD (2015)
DESCRIPTION

Shire plc is a global specialty biopharmaceutical company. Shire plc strive to develop best-in-class therapies across a core of rare disease areas including hematology, immunology, genetic diseases, neuroscience, and internal medicine with growing therapeutic areas in ophthalmics and oncology. Our diversified capabilities enable us to reach patients in more than 100 countries who are struggling to live their lives to the fullest.

DEAL STATS #
Overall 7 of 16
Sector (Life Science) 7 of 15
Type (Add-on Acquisition) 6 of 14
State (Pennsylvania) 1 of 1
Country (United States) 6 of 13
Year (2013) 2 of 2
Size (of disclosed) 4 of 12
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-03-25 SARcode Bioscience

Brisbane, California, United States

SARcode Bioscience Inc. is a biopharmaceutical company based in Brisbane, California.

Buy $160M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-01-17 Dermagraft

Canton, Massachusetts, United States

Dermagraft is a provider of nonhealing diabetic foot ulcers. Dermagraft is headquartered in Canton, Massachusetts.

Sell -
Mergr

Product

Company

Legal